We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $127B Turnover 40.17%
1-Year Est. Return 46.06%
 

Marshall Wace is a British firm that runs long/short hedge funds. Its strategies combine computer-driven and traditional company analysis, applied worldwide and mostly to long/short equity. Paul Marshall, formerly head of European equities at Mercury Asset Management, and Ian Wace, formerly head of equities trading at Deutsche Bank, founded it in 1997. In 2002 it launched TOPS, a system that gathers investment ideas from equity professionals and uses algorithms to turn them into stock portfolios. In 2015 Marshall Wace formed a long-term partnership with KKR, a private equity and credit investor that took an ownership interest in the firm.

This Fund
S&P 500
This Quarter Est. Return
+4.69%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$15.2B
AUM Growth
+$1.14B
Cap. Flow
+$780M
Cap. Flow %
5.13%
Top 10 Hldgs %
15.87%
Holding
1,269
New
352
Increased
317
Reduced
269
Closed
320
Avg Time Held Equity + Options
0.6 years
Top 10 Avg Time Held Equity + Options
0.9 years
Top 20 Avg Time Held Equity + Options
0.5 years
Avg Time Held Equity only
0.6 years
Top 10 Avg Time Held Equity only
0.9 years
Top 20 Avg Time Held Equity only
0.5 years

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$124M
2
TXN icon
Texas Instruments
TXN
+$113M
3
UNH icon
UnitedHealth
UNH
+$106M
4
PM icon
Philip Morris
PM
+$106M
5
TJX icon
TJX Companies
TJX
+$93.3M

Sector Composition

Rank Sector Weight
1 Healthcare 21.53%
2 Consumer Discretionary 12.4%
3 Technology 12.24%
4 Communication Services 11.12%
5 Financials 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TMUS icon
1
T-Mobile US
TMUS
$179B
$483M 3.17%
8,392,754
-326,600
-4% -$17.1M
2013 Q2
14 quarters
ZTS icon
2
Zoetis
ZTS
$33B
$444M 2.92%
8,296,280
-4,351,373
-34% -$221M
2013 Q2
14 quarters
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$3.59T
$319M 2.1%
8,043,380
+1,102,300
+16% +$44.1M
2015 Q3
5 quarters
AMZN icon
4
Amazon
AMZN
$2.88T
$195M 1.28%
5,205,140
+3,157,880
+154% +$124M
2013 Q2
14 quarters
SHPG
5
DELISTED
Shire pic
SHPG
$176M 1.16%
1,035,554
+137,216
+15% +$24.3M
2015 Q4
4 quarters
LOW icon
6
Lowe's Companies
LOW
$128B
$174M 1.14%
2,441,272
+550,267
+29% +$38.9M
2014 Q1
11 quarters
CMCSA icon
7
Comcast
CMCSA
$87.6B
$165M 1.09%
4,783,882
+315,940
+7% +$10.6M
2013 Q2
14 quarters
CHTR icon
8
Charter Communications
CHTR
$15.3B
$158M 1.04%
550,038
-199,239
-27% -$53.7M
2015 Q1
7 quarters
HUM icon
9
Humana
HUM
$53.6B
$151M 0.99%
738,557
+451,823
+158% +$86.2M
2015 Q1
7 quarters
SPGI icon
10
S&P Global
SPGI
$137B
$148M 0.97%
1,377,591
+5,563
+0.4% +$665K
2016 Q2
2 quarters
META icon
11
Meta Platforms (Facebook)
META
$1.64T
$131M 0.86%
1,136,233
-313,321
-22% -$38.5M
2014 Q1
11 quarters
PM icon
12
Philip Morris
PM
$302B
$130M 0.85%
1,416,549
+1,145,602
+423% +$106M
2016 Q1
3 quarters
BAC icon
13
Bank of America
BAC
$350B
$129M 0.85%
5,849,296
+2,661,050
+83% +$51.3M
2016 Q1
3 quarters
MON
14
DELISTED
Monsanto Co
MON
$122M 0.8%
1,163,299
+177,934
+18% +$18.2M
2013 Q2
14 quarters
C icon
15
Citigroup
C
$206B
$122M 0.8%
2,053,656
+320,256
+18% +$17.3M
2013 Q2
14 quarters
UNH icon
16
UnitedHealth
UNH
$358B
$116M 0.76%
721,804
+712,343
+7,529% +$106M
2015 Q3
5 quarters
TXN icon
17
Texas Instruments
TXN
$284B
$115M 0.76%
+1,581,130
New +$113M
2016 Q4
0 quarters
CI icon
18
Cigna
CI
$77.7B
$114M 0.75%
858,278
+632,499
+280% +$82.8M
2014 Q2
10 quarters
LUV icon
19
Southwest Airlines
LUV
$22.6B
$110M 0.72%
2,207,361
-70,649
-3% -$3.17M
2014 Q4
8 quarters
TJX icon
20
TJX Companies
TJX
$149B
$109M 0.71%
2,893,078
+2,469,032
+582% +$93.3M
2015 Q3
5 quarters
AAP icon
21
Advance Auto Parts
AAP
$2.68B
$108M 0.71%
639,569
-538,437
-46% -$84.6M
2013 Q2
14 quarters
DHR icon
22
Danaher
DHR
$167B
$108M 0.71%
1,563,946
+861,888
+123% +$59.8M
2014 Q4
8 quarters
MJN
23
DELISTED
Mead Johnson Nutrition Company
MJN
$106M 0.7%
1,504,924
+399,133
+36% +$29.7M
2015 Q4
4 quarters
BCR
24
DELISTED
CR Bard Inc.
BCR
$102M 0.67%
456,166
+71,747
+19% +$15.6M
2014 Q2
10 quarters
INTU icon
25
Intuit
INTU
$90.7B
$101M 0.66%
879,987
+188,387
+27% +$21.1M
2014 Q1
11 quarters

Similar funds

Marshall Wace's Q4 2016 Portfolio in Review

As of Q4 2016, Marshall Wace held 1,269 positions worth $15.2B, up 8.1% from $14.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $780M of net new capital in Q4 2016, opening 352 new positions and adding to 317 existing holdings. Its largest new stake was Texas Instruments: 1,581,130 shares worth $115M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Zoetis, an estimated $221M trimmed.

  • Marshall Wace's largest Q4 2016 buy was Texas Instruments: 1,581,130 shares worth $115M.
  • Marshall Wace added most to Amazon in Q4 2016, an estimated $124M increase.
  • Marshall Wace's biggest Q4 2016 reduction was Zoetis, cutting an estimated $221M.
  • Marshall Wace fully exited iShares MSCI Emerging Markets ETF in Q4 2016, selling an estimated $240M.
  • Marshall Wace's ten largest holdings make up 16% of its $15.2B portfolio in Q4 2016.
  • Marshall Wace opened 352 new positions and closed 320 in Q4 2016.
  • Marshall Wace's portfolio value rose 8.1% quarter-over-quarter to $15.2B.

Based on Marshall Wace's 13F filing for Q4 2016, filed 10 Feb 2017.